• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Republic of Korea Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery - Product Image

Republic of Korea Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

  • ID: 2011729
  • December 2011
  • 89 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • Apex Biotechnology Corp.
  • Bayer HealthCare AG
  • F. Hoffmann-La Roche Ltd.
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • MORE

Republic of Korea Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Summary

GlobalData’s new report, “Republic of Korea Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery” provides key market data on the Republic of Korea Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • Apex Biotechnology Corp.
  • Bayer HealthCare AG
  • F. Hoffmann-La Roche Ltd.
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • MORE

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Diabetes Care Devices In Republic of Korea
3.1 Diabetes Care Devices, Market Segmentation
3.2 Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Actual, 2003-2017
3.3 Diabetes Care Devices Market, Republic of Korea, Revenue Mix ($m), 2010
3.4 Diabetes Care Devices Market, Republic of Korea, Category Contribution (%), 2010
3.5 Diabetes Care Devices, Republic of Korea, Category Volume (Units), 2003-2017
3.6 Diabetes Care Devices, Republic of Korea, Company share (2009-2010)
4 Glucose Monitoring In Republic of Korea
4.1 Glucose Monitoring, Market Segmentation
4.2 Glucose Monitoring Market, Republic of Korea, Revenue Mix ($m), 2010
4.3 Glucose Monitoring Market, Republic of Korea, Segment Contribution (%), 2010
4.4 Glucose Monitoring Overall Revenue (2003-2017)
4.4.1 Blood Glucose Meters Revenue (2003-2017)
4.5 Glucose Monitoring Overall Volume (2003-2017)
4.5.1 Blood Glucose Meters Volume (2003-2017)
4.6 Glucose Monitoring Average Price (2003-2017)
4.7 Glucose Monitoring Distribution Share (2009-2010)
4.8 Glucose Monitoring, Republic of Korea, Company share (2009-2010)
5 Insulin Delivery In Republic of Korea
5.1 Insulin Delivery, Market Segmentation
5.2 Insulin Delivery Market, Republic of Korea, Revenue Mix ($m), 2010
5.3 Insulin Delivery Market, Republic of Korea, Segment Contribution (%), 2010
5.4 Insulin Delivery Overall Revenue (2003-2017)
5.4.1 Insulin Pens Revenue (2003-2017)
5.4.2 Insulin Pumps Revenue (2003-2017)
5.5 Insulin Delivery Overall Volume (2003-2017)
5.5.1 Insulin Pens Volume (2003-2017)
5.5.2 Insulin Pumps Volume (2003-2017)
5.6 Insulin Delivery Average Price (2003-2017)
5.7 Insulin Delivery Distribution Share (2009-2010)
5.8 Insulin Delivery, Republic of Korea, Company share (2009-2010)
6 Overview of Key Companies in Republic of Korea Diabetes Care Devices Market
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Share in the Republic of Korea Diabetes Care Devices Market
6.2 LifeScan, Inc.
6.2.1 Company Overview
6.2.2 Share in the Republic of Korea Diabetes Care Devices Market
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Share in the Republic of Korea Diabetes Care Devices Market
6.4 Novo Nordisk A/S
6.4.1 Company Overview
6.4.2 Share in the Republic of Korea Diabetes Care Devices Market
6.5 Sanofi
6.5.1 Company Overview
6.5.2 Share in the Republic of Korea Diabetes Care Devices Market
6.6 Eli Lilly and Company
6.6.1 Company Overview
6.6.2 Share in the Republic of Korea Diabetes Care Devices Market
6.7 ARKRAY, Inc.
6.7.1 Company Overview
6.8 Bayer HealthCare AG
6.8.1 Company Overview
6.9 Terumo Corporation
6.9.1 Company Overview
6.10 Becton, Dickinson and Company
6.10.1 Company Overview
6.11 Apex Biotechnology Corp.
6.11.1 Company Overview
6.12 NIPRO CORPORATION
6.12.1 Company Overview
6.13 Medtronic, Inc.
6.13.1 Company Overview
6.14 Animas Corporation
6.14.1 Company Overview
7 Diabetes Care Devices Market Pipeline Products
8 Appendix
8.1 Definitions of Markets Covered in the Report
8.1.1 Diabetes Care Devices
8.2 Research Methodology
8.3 Secondary Research
8.4 Primary Research
8.5 Models
8.6 Forecasts
8.7 Expert Panels
8.8 GlobalData Consulting
8.9 Currency Conversion
8.10 Contact Us
8.11 Disclaimer

1.1 List of Tables
Table 1: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Actual, 2003-2017
Table 2: Diabetes Care Devices Market, Republic of Korea, Category Contribution (%), 2010
Table 3: Diabetes Care Devices, Republic of Korea, Cross-Segment Analysis, 2003-2017
Table 4: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 5: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 6: Diabetes Care Devices, Republic of Korea, Category Volume (Units), 2003-2017
Table 7: Diabetes Care Devices, Republic of Korea, Category Volume (Units), Historic, 2003-2010
Table 8: Diabetes Care Devices, Republic of Korea, Category Volume (Units), Forecast, 2010-2017
Table 9: Diabetes Care Devices, Republic of Korea, Company share by Revenue ($m), USD Actual, 2009-2010
Table 10: Glucose Monitoring Market, Republic of Korea, Segment Contribution (%), 2010
Table 11: Glucose Monitoring, Republic of Korea, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 12: Glucose Monitoring, Republic of Korea, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 13: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Revenue ($m), USD Actual, Historic, 2003-2010
Table 14: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Revenue ($m), USD Actual, Forecast, 2010-2017
Table 15: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment, Historic, 2003-2010
Table 16: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment, Forecast, 2010-2017
Table 17: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Volume (Units), Historic, 2003-2010
Table 18: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Volume (Units), Forecast, 2010-2017
Table 19: Glucose Monitoring, Republic of Korea, Average Price ($), Historic, 2003-2010
Table 20: Glucose Monitoring, Republic of Korea, Average Price ($), Forecast, 2010-2017
Table 21: Glucose Monitoring, Republic of Korea, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 22: Glucose Monitoring, Republic of Korea, Company share by Revenue ($m), USD Actual 2009-2010
Table 23: Insulin Delivery Market, Republic of Korea, Segment Contribution (%), 2010
Table 24: Insulin Delivery, Republic of Korea, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 25: Insulin Delivery, Republic of Korea, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 26: Insulin Pens, Republic of Korea, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 27: Insulin Pens, Republic of Korea, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 28: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue ($m), USD Actual, Historic, 2003-2010
Table 29: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue ($m), USD Actual, Forecast, 2010-2017
Table 30: Insulin Delivery, Republic of Korea, Volume (Units) by Segment, Historic, 2003-2010
Table 31: Insulin Delivery, Republic of Korea, Volume (Units) by Segment, Forecast, 2010-2017
Table 32: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 33: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 34: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume (Units), Historic, 2003-2010
Table 35: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume (Units), Forecast, 2010-2017
Table 36: Insulin Delivery, Republic of Korea, Average Price ($), Historic, 2003-2010
Table 37: Insulin Delivery, Republic of Korea, Average Price ($), Forecast, 2010-2017
Table 38: Insulin Delivery, Republic of Korea, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 39: Insulin Delivery, Republic of Korea, Company share by Revenue ($m), USD Actual 2009-2010
Table 40: Diabetes Care Devices Market Pipeline Products
Table 41: USD to Local Currency, Republic of Korea, Average Actual Rate 2003-2010

1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation
Figure 2: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Actual, 2003-2017
Figure 3: Diabetes Care Devices Market, Republic of Korea, Revenue Mix ($m), 2010
Figure 4: Diabetes Care Devices Market, Republic of Korea, Category Contribution (%), 2010
Figure 5: Diabetes Care Devices, Republic of Korea, Cross-Segment Analysis, 2003-2017
Figure 6: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 7: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 8: Diabetes Care Devices, Republic of Korea, Category Volume (Units), 2003-2017
Figure 9: Diabetes Care Devices, Republic of Korea, Category Volume (Units), Historic, 2003-2010
Figure 10: Diabetes Care Devices, Republic of Korea, Category Volume (Units), Forecast, 2010-2017
Figure 11: Diabetes Care Devices, Republic of Korea, Company share (%), 2010
Figure 12: Glucose Monitoring, Market Segmentation
Figure 13: Glucose Monitoring Market, Republic of Korea, Revenue Mix ($m), 2010
Figure 14: Glucose Monitoring Market, Republic of Korea, Segment Contribution (%), 2010
Figure 15: Glucose Monitoring, Republic of Korea, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 16: Glucose Monitoring, Republic of Korea, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 17: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Revenue ($m), USD Actual, Historic, 2003-2010
Figure 18: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 19: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment, Historic, 2003-2010
Figure 20: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment, Forecast, 2010-2017
Figure 21: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Volume (Units), Historic, 2003-2010
Figure 22: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Volume (Units), Forecast, 2010-2017
Figure 23: Glucose Monitoring, Republic of Korea, Company share (%), 2010
Figure 24: Insulin Delivery, Market Segmentation
Figure 25: Insulin Delivery Market, Republic of Korea, Revenue Mix ($m), 2010
Figure 26: Insulin Delivery Market, Republic of Korea, Segment Contribution (%), 2010
Figure 27: Insulin Delivery, Republic of Korea, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 28: Insulin Delivery, Republic of Korea, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 29: Insulin Pens, Republic of Korea, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 30: Insulin Pens, Republic of Korea, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 31: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue ($m), USD Actual, Historic, 2003-2010
Figure 32: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 33: Insulin Delivery, Republic of Korea, Volume (Units) by Segment, Historic, 2003-2010
Figure 34: Insulin Delivery, Republic of Korea, Volume (Units) by Segment, Forecast, 2010-2017
Figure 35: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 36: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 37: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume (Units), Historic, 2003-2010
Figure 38: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume (Units), Forecast, 2010-2017
Figure 39: Insulin Delivery, Republic of Korea, Company share (%), 2010
Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%),Republic of Korea Diabetes Care Devices Market, 2010
Figure 41: LifeScan, Inc., Company Share (%),Republic of Korea Diabetes Care Devices Market, 2010
Figure 42: Abbott Laboratories, Company Share (%),Republic of Korea Diabetes Care Devices Market, 2010
Figure 43: Novo Nordisk A/S, Company Share (%),Republic of Korea Diabetes Care Devices Market, 2010
Figure 44: Sanofi, Company Share (%),Republic of Korea Diabetes Care Devices Market, 2010
Figure 45: Eli Lilly and Company, Company Share (%),Republic of Korea Diabetes Care Devices Market, 2010

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Abbott Laboratories
Novo Nordisk A/S
Sanofi
Eli Lilly and Company
ARKRAY, Inc.
Bayer HealthCare AG
Terumo Corporation
Becton, Dickinson and Company
Apex Biotechnology Corp.
NIPRO CORPORATION
Medtronic, Inc.
Animas Corporation

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos